Alexion Pharmaceuticals, Inc. · 2 months ago
Director AI and Robotics Transformation -MS
Gaithersburg
Full-time
Hybrid
Director/Executive
8+ years expAlexion Pharmaceuticals, Inc. is seeking a Director of AI and Robotics Transformation to lead the design and execution of AI and robotics initiatives within Manufacturing Sciences. This role involves driving multi-year transformation roadmaps, collaborating with expert functions, and ensuring projects align with business objectives while fostering a culture of continuous learning across the organization.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Develop, drive, and iteratively refine a functional specific AI and predictive science strategy aligned with business objectives and emerging trends
Develop, drive, and iteratively refine a functional specific Robotics strategy aligned with business objectives, emerging trends and Manufacturing of the Future
Define and maintain the functional roadmaps, ensuring prioritization and alignment with departmental transformation goals
Collaborate with expert functions (e.g. DSM) to manage end-to-end delivery of AI and predictive science projects, ensuring stakeholder engagement from requirements definition through PoC, pilot, and full production deployment
Lead and serve as a key contributor to functional matrix teams, fostering close collaboration with expert functions to deliver functional projects
Accelerate adoption by creating training programs, communication plans, and KPIs to measure impact and success
Partner with leadership to assess and adapt functional capabilities (talent, technology, capacity) to accelerate and scale delivery of the multi-year roadmap
Represent Manufacturing Sciences in transformation teams (e.g., MAST, RACT), ensuring functional requirements are met by actively influencing cross-functional decisions. Proactively share functional plans and progress with the wider department
Lead major cross-functional digital transformation projects when required
Qualification
Required
Strong leadership and strategic thinking skills, with a proven ability to drive organizational change
Deep understanding of Biopharmaceutical Development scientific processes and associated challenges
Demonstrated experience managing complex, multi-stakeholder projects and leading cross-functional teams
Substantial exposure to AI technologies and their application in scientific or operational contexts
Advanced Experience with Biopharmaceutical Drug Substance, Analytical or Drug product Development, or Clinical Manufacturing
Excellent communication and stakeholder engagement skills
Masters degree in a related field with 12 years of experience or PhD with 8 years of experience
Preferred
Passion for innovation and digital transformation
Ability to translate scientific needs into practical, scalable digital solutions
Collaborative mindset with a strong focus on delivering measurable outcomes
Experience in leading other engineers/scientists in the creation, modification, and troubleshooting of laboratory robotics & automation scripts
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
1001-5000 employees
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
BioWorld Financial Watch
2026-01-17
bloomberglaw.com
2025-12-20
Company data provided by crunchbase